Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Hydration Pharmaceuticals CoASX:HPC Earnings per Share (Diluted) is A$-0.01 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 263 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 91.63% on this metric.
During the past 3 years, the average EPS without NRIGrowth Rate was 51.10% per year.
During the past 5 years, The Hydration Pharmaceuticals Co's highest 3-Year average EPS without NRI Growth Rate was 51.10% per year. The lowest was 30.40% per year. And the median was 40.75% per year.
The Hydration Pharmaceuticals Co (ASX:HPC) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
The Hydration Pharmaceuticals Co Earnings per Share (Diluted) Related Terms
The Hydration Pharmaceuticals Co Earnings per Share (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Earnings per Share (Diluted) Chart
ASX:HPC vs SYY, USFD, PFGC: Earnings per Share (Diluted) Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co PE Ratio vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's PE Ratio distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's PE Ratio falls into.
The Hydration Pharmaceuticals Co Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of A$-0.01 mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Earnings per Share (Diluted) of A$-0.01 as of Dec. 2025. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #22 out of 263 companies in the Retail - Defensive industry, placing it in the top 8.4%.
Is The Hydration Pharmaceuticals Co's Earnings per Share (Diluted) too high?
The Hydration Pharmaceuticals Co's current Earnings per Share (Diluted) is A$-0.01. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #22 out of 263 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's Earnings per Share (Diluted) compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #22 out of 263 companies for Earnings per Share (Diluted). This places The Hydration Pharmaceuticals Co in the top 8% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Retail - Defensive company?
The median Earnings per Share (Diluted) among Retail - Defensive companies is 8.00, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Earnings per Share (Diluted) is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Earnings per Share (Diluted) is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Earnings per Share (Diluted) of A$-0.01. The current Earnings per Share (Diluted) is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Earnings per Share (Diluted) is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
